Drivers with Hemianopia Fail to Detect Pedestrians at Intersections
Driving simulator used to help learn how the visually impaired can drive safely
Source Newsroom: Massachusetts Eye and Ear
Newswise — BOSTON (March 14, 2014) — A diagnosis of hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma often means the end of driving.
In about half of the states in the United States and in many other countries, driving with hemianopia is prohibited. However, in some countries including Belgium, the Netherlands, the UK, Switzerland and Canada, driving with hemianopia is permitted after passing a specialized road test. Researchers at Massachusetts Eye and Ear/Schepens Eye Research Institute set out to determine the extent to which people with hemianopia can compensate for the lost vision when driving, with a long term goal of developing and evaluating devices and training that will assist them to drive more safely.
People with hemianopia have to look (scan) with eye and/or head movements toward the side of the field loss in order to see obstacles or hazards on that side. “The wide field of view that needs to be scanned at intersections presents an especially challenging situation for drivers with hemianopia as they have to scan larger angles than drivers with a full field of vision in order to see all of the intersection on the side of the field loss,” said lead author Alex Bowers, Ph.D.
Bowers and colleagues used a driving simulator to evaluate head scanning behaviors of 14 drivers with hemianopia and 12 drivers with normal vision as they approached intersections. Their results are described in the March 12 issue of Investigative Ophthalmology & Visual Science in the paper: Driving with Hemianopia: IV. Head Scanning and Detection at Intersections in a Simulator.
“We found that participants with hemianopia showed compensatory scanning patterns in that their first scan was usually to the side of their field loss. Drivers with right hemianopia tended to look to the right before looking to the left. By comparison, the normally sighted drivers and drivers with left hemianopia typically looked to the left first,” Bowers said.
However, the drivers with hemianopia did not compensate by making larger head scans to the side of their field loss, as needed. In fact, their head scans were generally smaller than those of drivers with normal vision. “Yet, you might have expected the opposite as drivers with hemianopia have to scan a long way (close to 90 degrees) in order to see of all of the intersection on the side of their field loss,” Bowers said.
Drivers with hemianopia, especially drivers with right hemianopia, had low detection rates for pedestrians that appeared on the side of their field loss. Analyses of the head scans at these intersections revealed that the detection failures were either because the driver never scanned to the side of their field loss, or because they scanned, but not far enough, Bowers said.
“We might have expected that drivers with hemianopia would have had lower rates of failing to scan than drivers with normal vision, but this wasn’t the case,” Bowers said.
The findings suggest that, although there is evidence of compensation for the hemifield loss in some aspects of their scanning at intersections, the scanning patterns employed by some drivers with hemianopia may be insufficient for safe driving. Based on these individual responses, some drivers might benefit from training tailored to the specific problem areas identified in the study, Bowers noted.
She went on to summarize, “Our results underscore the importance of individualized evaluations for people with hemianopia who wish to resume driving. While some of the participants in our study frequently did not head scan to the side of their field loss, others always scanned to that side. Individualized assessments are an important component of the special provisions (regulations) that enable drivers with visual field loss to demonstrate their ability to drive safely in specialized road tests in other countries.”
This research was supported by National Institutes of Health Grants EY12890 and EY018680. Authors included Alex R. Bowers, Egor Ananyev, Aaron J. Mandel, Robert B. Goldstein and Eli Peli, of Mass. Eye and Ear/Schepens Eye Research Institute and Harvard Medical School.
About Massachusetts Eye and Ear
Mass. Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Led by the Eaton-Peabody Laboratory in Otology, the Howe Laboratory in Ophthalmology and Schepens Eye Research Institute, Mass. Eye and Ear in Boston is the world's largest vision and hearing research center, offering hope and healing to patients everywhere through discovery and innovation. Mass. Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report’s “Best Hospitals Survey” has consistently ranked the Mass. Eye and Ear Departments of Otolaryngology and Ophthalmology as among the top hospitals in the nation.